Refine by MP, party, committee, province, or result type.

Results 31-45 of 47
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  The legislation provides for considerable oversight. In fact, every order has a mechanism for review. In addition, for those individuals who might not be happy with the review, there is recourse as well to the Federal Court. As well, in the broader context the process for regulat

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I know you've been studying it since the first question. Do you want to take it?

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I believe it would be most productive to start with the definitions. In the definitions it reads: “danger to human health or safety” means any unreasonable hazard—existing or potential—that is posed by a consumer product during or as a result of its normal or foreseeable use

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  A lot of how we improve the recovery rate will come from effective procedures. But a really important provision in Bill C-36 is through document retention. So should the bill pass, industry is required to retain one level up and one level down the supply chain of documents. That

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  The broad answer is that the government's view is that Parliament has enacted valid legislation regarding tobacco. Tobacco use is a unique social and health problem, and the Tobacco Act was developed specifically to try to manage that problem. In addition, the Tobacco Act has bee

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  There are probably a number of ways I can reassure you in that regard. First of all, the constraint of the legislation is clear. It's laid out in the legislation itself. There are clear restrictions, for example, on inspectors' powers. Inspectors are limited to what is described

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  No. I'll ask my colleague to elaborate.

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  Thank you for the question. I have a four-year-old. I think he's just coming out of the eating foreign objects phase--I hope. What's developed with cadmium today is probably a very good example of the way we might approach product safety differently had we had these provisions

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I apologize, but for greater clarity, I prefer answering in English. I believe I know exactly the correspondence you're referring to, and yes, we have analyzed it in considerable detail and the short answer to your question is yes. We believe that we are fully in line. Did you

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I wish I could explain the concern. It's very explicit in the legislation. We've taken great pains to make it clear that the legislation does not apply to natural health products. Some of the concerns do go beyond that.

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  No, there is no way. There is a way, but it would have to come back before Parliament to be amended so that the scope of the legislation would be changed--for example, to remove the provision in subclause 4(3). So yes, there is a way, but certainly it would be the purview of parl

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I think the distinction in particular is that for clause 17, we are contemplating the release of information to the public, whereas in clause15, we are contemplating the release of information to another government. We are raising the standards somewhat in terms of its being very

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  It is “to a person or a government that carries out functions relating to the protection of human health or safety”.

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  That's correct, yes.

October 19th, 2010Committee meeting

Athana Mentzelopoulos

Health committee  I hesitate to characterize the senator's concerns, but as I understand them, he was concerned, as you say, with the disclosure of personal information. We imagine, for example--and I'm going to ask Mr. Ianiro to fill in the blanks--a case where we receive a report of an injury o

October 19th, 2010Committee meeting

Athana Mentzelopoulos